Today: September 19, 2018, 9:22 am
  
Health

Insulin Market report offers Market | Size | Share | Forecast 2018 -2024

Insulin Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024
Insulin Market report offers Market
Insulin Market report offers Market
PR-Inside.com: 2018-06-14 14:44:30
Insulin Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

Increase in the prevalence of diabetes, technological advancements in the insulin administration devices such as pen devices, change in the lifestyle leads to early onset of diabetes, the rise in the incidence of obesity, and favourable reimbursement policies expected to boost the insulin market over the forecast period. Moreover, product approval for insulin biosimilars in January 2016 by FDA for Basaglar biosimilar in U.S, increase in the awareness about the insulin usage, ease of administration, availability of the wider products, and upsurge in the demand for insulin analogues are anticipated propel the market over the forecast period. However, stringent regulatory policies for product approval, high cost of the insulin, and manufacturing complexities might hamper the growth of insulin market over the forecast timeframe.


A sample of this report is available upon request @

www.precisionbusinessinsights.com/market-reports/global-insulin- ..



Global insulin market is segmented on the product type, diabetes type, and end user

Based on the product type, insulin market is segmented into the following:

• Ultra-short acting insulin

• Short acting insulin

• Intermediate acting insulin

• Long acting insulin

• Premixed insulin

Based on the diabetes type, insulin market is segmented into the following:

• Type 1 diabetes

• Type 2 diabetes

Based on the end user, insulin market is segmented into the following:

• Hospital Pharmacies

• Retail Pharmaices

• Online Pharmacies

To view TOC of this report is available upon request @

www.precisionbusinessinsights.com/market-reports/global-insulin- ..



Global insulin market is in the developed stage with several players operating in the market. Increase in the prevalence of diabetes and obesity, increase in the R&D activities for the development of insulin such as oral insulin and insulin patches is anticipated to propel the insulin market in the forthcoming years. Acquisitions & mergers, collaborations, product approval and launchings, and patent fillings for the devices are some key strategies followed by the companies. For instance, in February 2016, Eli Lilly and Co. acquired Glycostasis, Inc. for the development of insulin. In addition, in August 2016, Emperra has launched blutooth enabled insulin delivering device in Germany.

Need more information about this report @

www.precisionbusinessinsights.com/market-reports/global-insulin- ..



Geographically, the insulin market is segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America anticipated to healthy growth rate owing to increase in the prevalence of diabetes in the U.S. (According to American Diabetes Association, the prevalence of diabetes in 2015 is 30.3 Mn or 9.4% in U.S.), rise in the healthcare expenditure, and technological advancements in insulin administration. Europe holds a key share in the market, which is attributed to increase in the prevalence of diabetes majorly in Germany, Russia, and U.K (according to Diabetes UK 2016, about 3.6 Mn people are suffering from diabetes in the U.K. region), rise in the obese population due to change in life style, increased R&D activities, and surge in demand for minimally invasive administration might propel the revenue growth of insulin market over the forecast years. Asia Pacific exhibiting significant growth owing to increase in diabetes population majorly in India and China (according to the International Diabetes Federation, in 2015, China around 96.2 million diabetic patients and India 66.8 million patients are suffering from diabetes.), rise in healthcare expenditure, and adoption of insulin in Asia Pacific region expected to bolster the insulin market.

Some of the players in Insulin market are Eli Lilly and Co. (U.S.), Merck & Co, Inc. (U.S.), Novo Nordisk A/S (Denmark), Sanofi (France), GlaxoSmithKline Plc. (U.K.). Biocon Ltd. (India), and Wockhardt Ltd. (India) to name a few.

Get access to full summary @

www.precisionbusinessinsights.com/market-reports/global-insulin- ..

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ www.precisionbusinessinsights.com

Press Information
Precision Business Insights
Kemp House,


152 – 160 City Road,


London EC1V 2NX

satya
Marketing Lead
+1-866-598-1553
email
www.precisionbusinessinsights.com


# 814 Words
Related Articles
More From The Author
Cardiac Guide wire and Catheters Market | [..]
Cardiac Guide wire and Catheters Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, [..]
Graft Versus Host Disease Treatment Market Size [..]
Global graft versus host disease treatment market was valued at US $ XX Mn and expected to grow at 5.5% [..]
Aptamers Market report offers Market | Size [..]
Aptamers Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry [..]
Animal Medicated Feed Market | Size | [..]
Animal Medicated Feed Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth [..]
Animal Feed Micronutrients Market | Size | [..]
Animal Feed Micronutrients Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth [..]
 
More From Health
NSAV SUBSIDIARY SIGNS MAJOR AGREEMENT WITH ELI [..]
Net Savings Link, Inc. (OTC: NSAV), a medical technology and software company, announced today that its subsidiary, Shanghai based [..]
Cadrock Secures US$5m for Therapy Targeting $35 [..]
- Enrolls first clinical trial patients in Sydney, Australia SYDNEY, Sept 4, 2018 - (ACN Newswire) - Cadrock Pty Ltd, [..]
NEGTEC launches Crowdfunding Portal promoting Regenerative Medicine
Dream-Kicker.com to offer donation-based, cryptocurrency support for cutting-edge regenerative medicine and medical equipment TOKYO, [..]
NSAV ANNOUNCES AGREEMENT TO ACQUIRE MAJOR STAKE [..]
Net Savings Link, Inc. (OTC: NSAV), a medical technology and software company, announced today that the Company has acquired a [..]
Novotech the Asia-Pacific CRO named Top 10 [..]
SYDNEY, Aug 23, 2018 - (ACN Newswire) - Asia-Pacific specialist CRO Novotech has been selected as one of the Top [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.